Fig. 6From: Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through the inhibition of pro-inflammatory enzymes and cytokinesEffects of calipteryxin and (3’S,4’S)-3’,4’-disenecioyloxy-3’,4’-dihydroseselin on p-IKKα/β (a), p-IκBα (b), and IκBα (c) protein expression levels in time course experimentsBack to article page